| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00034 | 1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.00037 | 1 |